Navigation Links
Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
Date:10/1/2013

tion-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Information about Lilly is available at www.lilly.com.  

CR-LLY

[i] According to the National Center for Higher Education Management Systems: 
http://www.higheredinfo.org/dbrowser/?year=2009&level=nation&mode=graph&state=0&submeasure=27  

Refer to:
Stephanie Libous (RF|Binder), +1(212) 994-7588, Stephanie.Libous@rfbinder.com 
Morry Smulevitz (Lilly), +1(317) 651-5567, smulevitzmb@lilly.com 

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
2. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
3. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
4. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
5. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
6. Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
7. Dr. Marschall S. Runge Elected to Lilly Board of Directors
8. Lilly Reports Second-Quarter 2013 Results
9. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
10. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
11. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 The Canadian Society for Vascular Surgery (CSVS) ... or procedures that are commonly ordered but not ... Choosing Wisely Canada.  The list identifies five (5) ... patients and physicians about what care is really ... Surgery,s list identified the following five (5) recommendations: ...
(Date:6/2/2015)... 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ) ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... Surgical Incision Closures in US$ Million by the following Product ...
(Date:6/2/2015)... RALEIGH, N.C. , June 2, 2015 BioDelivery ... to weather conditions, the presentation by Dr. Mark A. ... been changed to 2:30 PM Eastern time. Jefferies ... Time Grand Hyatt, New York City ... and can be accessed at www.bdsi.com .  For those ...
Breaking Medicine Technology:As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Surgical Incision Closures - Global Strategic Business Report 2015 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3
... Benefit over Placebo Larger at One Year than ... 11, 2007,/PRNewswire-FirstCall/ -- Medivation, Inc. today announced that ... Phase 2 study in mild-to- moderate Alzheimer's,disease were ... months. Importantly, on every endpoint studied, the benefits,of ...
... Study Presented at Federation of,Clinical Immunology Societies ... 11, 2007 /PRNewswire-FirstCall/ --,Orchestra Therapeutics, Inc. (Bulletin ... its completed Phase II open-label study of,NeuroVax(TM), ... for the treatment of relapsing-remitting multiple sclerosis,(MS). ...
Cached Medicine Technology:Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 2Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 3Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 4Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 5Medivation's Dimebon Maintains Statistically Significant Benefit on,All Five Efficacy Endpoints in Alzheimer's Disease Trial After One,Year of Therapy 6Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5
(Date:6/3/2015)... First Choice Emergency Room , ... the United States, announced that it is opening its ... , “I am pleased to announce that we ... facility in the San Antonio area,” said Dr. James ... Room. , First Choice Emergency Room is revolutionizing ...
(Date:6/3/2015)... 2015 On May 29, 2015, Health ... effective immediately, which now permits the use of gluten-free ... as ingredients. The MA is a prelude to an ... should be aware that, unlike the unlimited use of ... are restrictions for gluten-free oat products sold in Canada. ...
(Date:6/3/2015)... Foot and Ankle Specialists of the ... ( Clarksville Division ) was recently presented with the ... Wound Care (SAWC) and the American Podiatric Medical Association ... The Conference was held on April 29-May 3, 2015, ... Antonio, TX. , Dr. Casey Friske graduated from ...
(Date:6/3/2015)... June 03, 2015 Veatch Consulting Services ... Since they first opened for business in April 2006, ... the needs of their clients. Each and every year ... Dental Consulting is proud to say that they are ... A new feature recently added this year is the ...
(Date:6/3/2015)... June 03, 2015 evigilo, a ... multi-channel solutions, reported of its "behind-the-scenes" involvement in ... few months. Since March this year, an unusual ... inflicting the South-American country, putting millions in danger. ... gas into the atmosphere. "evigilo's technology, adopted by ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Thousands of Lives Saved, Millions Protected in Chile 2
... Accuro Healthcare Solutions, Inc.,announced today it has filed a ... a proposed initial public offering of,its common stock. The ... range,for the offering has not yet been determined., ... offering, and Citi,and Piper Jaffray are acting as joint ...
... New Ad Campaign Debuts During Super Bowl, ... National Drug Control Policy (ONDCP) is launching its ... prescription drug abuse. This,national public awareness campaign will ... is ONDCP,s first paid TV advertising targeting,parents in ...
... can have grave consequences for the patient. Such consequences ... and treatment. The treatment is based on clinical criteria. ... parasites present in a skin lesion as accurately as ... assess the treatment outcome. , Van der Meide ...
... sciences, protocols provide individual sets of instructions ... their own laboratory. These documents provide instructions ... that include the safety bias, procedural equipment, ... the experiment. , The Protocols ...
... Reinforce Strength of ... Partnership, ... Medical Systems (NYSE: VAR ) and BrainLAB AG are today ... platform, which combines the most successful technologies,from both companies to offer ...
... Jan. 24 Sports,and nutritional product manufacturer, Natural ... announced today that it will,launch in February 2008, ... bar with a FUSION of rich and 100% ... 100% all natural nutrition bars are loaded with ...
Cached Medicine News:Health News:ONDCP Launches First Major Initiative to Combat Teen Prescription Drug Abuse 2Health News:ONDCP Launches First Major Initiative to Combat Teen Prescription Drug Abuse 3Health News:ONDCP Launches First Major Initiative to Combat Teen Prescription Drug Abuse 4Health News:Improved diagnosis of cutaneous leishmaniasis thanks to new techniques 2Health News:Springer launches Springer Protocols 2Health News:Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform 2Health News:Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform 3Health News:Natural Nutrition Launches All Natural FUSION Fruit Bar Line 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: